Jazz Pharmaceuticals plc (JAZZ)

Jazz Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,218	1,506	881.48	591.45	1,058	637.34
Short-Term Investments	400	120	-	-	1,075	440
Trading Asset Securities	0.01	3.78	-	-	-	-
Cash & Short-Term Investments	2,618	1,630	881.48	591.45	2,133	1,077
Cash Growth	64.40%	84.93%	49.04%	-72.27%	97.97%	30.34%
Receivables	723.64	705.79	651.49	563.36	396.49	355.99
Inventory	539.3	597.04	714.06	1,073	95.4	78.61
Prepaid Expenses	155.13	185.48	91.91	131.41	62.42	39.43
Other Current Assets	354.2	317.03	267.19	252.39	152.49	78.9
Total Current Assets	4,390	3,435	2,606	2,611	2,840	1,630
Property, Plant & Equipment	253.59	234.99	301.38	343.42	257.1	270.89
Long-Term Investments	4.3	4.7	5.5	5	4.5	4.5
Goodwill	1,805	1,753	1,693	1,828	958.3	920.02
Other Intangible Assets	5,144	5,418	5,794	7,152	2,195	2,441
Long-Term Deferred Tax Assets	583.22	477.83	376.25	311.1	254.92	221.4
Long-Term Deferred Charges	4.4	6.48	9.25	12.03	5.24	7.43
Other Long-Term Assets	70.93	62.76	49.64	35.81	21.22	43.41
Total Assets	12,256	11,393	10,835	12,299	6,536	5,539
Accounts Payable	85.43	102.75	90.76	100.3	26.95	45.73
Accrued Expenses	805.32	748.21	757.86	588.41	315.16	249.44
Current Portion of Long-Term Debt	31	604.95	31	46.23	249.16	34.24
Current Portion of Leases	19.1	19.45	15.94	15.76	14.46	12.73
Current Income Taxes Payable	54.97	35.07	7.72	9.61	25.2	10.97
Current Unearned Revenue	-	-	0.46	2.09	2.55	4.72
Other Current Liabilities	34.16	26.26	29.46	46.9	20.28	6.66
Total Current Liabilities	1,030	1,537	933.19	809.3	653.75	364.49
Long-Term Debt	6,083	5,111	5,693	6,019	1,849	1,575
Long-Term Leases	71.12	64.26	77.05	93.47	140.04	151.23
Long-Term Unearned Revenue	-	-	-	0.46	2.32	4.86
Long-Term Deferred Tax Liabilities	791.78	847.71	944.34	1,301	130.4	224.1
Other Long-Term Liabilities	108.57	96.3	101.6	110.73	101.15	108.71
Total Liabilities	8,085	7,656	7,750	8,333	2,876	2,428
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	3,838	3,700	3,477	3,535	2,634	2,266
Retained Earnings	936.23	878.66	733.59	830.23	1,160	1,068
Comprehensive Income & Other	-602.87	-841.62	-1,125	-399.83	-133.83	-222.87
Total Common Equity	4,171	3,737	3,086	3,965	3,660	3,111
Shareholders' Equity	4,171	3,737	3,086	3,965	3,660	3,111
Total Liabilities & Equity	12,256	11,393	10,835	12,299	6,536	5,539
Total Debt	6,204	5,800	5,817	6,174	2,252	1,773
Net Cash (Debt)	-3,586	-4,170	-4,936	-5,583	-119.4	-695.38
Net Cash Per Share	-52.70	-57.86	-78.92	-93.53	-2.11	-12.08
Filing Date Shares Outstanding	60.45	62.35	63.33	61.74	56.33	56.13
Total Common Shares Outstanding	60.44	62.26	63.21	61.63	56.17	56.14
Working Capital	3,360	1,899	1,673	1,802	2,186	1,266
Book Value Per Share	69.01	60.03	48.82	64.34	65.15	55.41
Tangible Book Value	-2,778	-3,434	-4,401	-5,015	506.39	-250.01
Tangible Book Value Per Share	-45.96	-55.16	-69.63	-81.36	9.02	-4.45
Land	70.76	70.91	68.94	64.01	47.56	47.05
Machinery	118.03	107.57	100.49	99.73	63.81	56.59
Construction In Progress	30.65	18.66	67.39	86.51	7.26	5.15
Leasehold Improvements	71.95	67.72	64.78	66.32	54.11	52.29

Source: S&P Capital IQ. Standard template. Financial Sources.